Neurexin 3 (NRXN3) is a presynaptic cell adhesion molecule that mediates trans-synaptic interactions and plays crucial roles in synapse formation, function, and plasticity. NRXN3 has unique expression patterns and binding properties compared to other neurexin family members[1][^2].
Key points:
Nrxn3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NRXN3 is the third member of the neurexin family, with distinct expression patterns and functions in the nervous system.
| Property | Value |
|---|---|
| Protein Name | Neurexin 3 |
| Gene Symbol | NRXN3 |
| UniProt ID | Q9UHD8 |
| Molecular Weight | ~180 kDa (alpha), ~160 kDa (beta) |
| Subcellular Localization | Presynaptic membrane, synaptic vesicles |
| Protein Family | Neurexin family (NRXN1, NRXN2, NRXN3) |
NRXN3 contains structural domains similar to other neurexins[^3]:
NRXN3 undergoes alternative splicing at multiple sites, creating splice variants with different ligand binding properties[^4]. This allows precise spatial and temporal regulation of synaptic connections.
NRXN3 performs several critical functions at presynaptic terminals[5][6]:
NRXN3 exhibits unique expression patterns in the brain[^7]:
| Brain Region | Expression Level |
|---|---|
| Cerebral Cortex | High - layer 5 pyramidal neurons |
| Hippocampus | Moderate-high - CA3 region |
| Nucleus Accumbens | High - medium spiny neurons |
| Ventral Tegmental Area | Moderate - dopaminergic neurons |
| Amygdala | Moderate - basolateral complex |
| Hypothalamus | Low-moderate |
NRXN3 forms trans-synaptic complexes with[^8]:
NRXN3 has the strongest association with addiction among neurexins[^9]:
| Strategy | Target | Status |
|---|---|---|
| Gene therapy | Restore NRXN3 in reward circuits | Experimental |
| Small molecules | Stabilize NRXN3-ligand interactions | Research |
| Behavioral interventions | Target NRXN3-linked pathways | Clinical |
The study of Nrxn3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Neurexin family in synaptic adhesion. Neuron 2010[^2]: NRXN3 and addiction genetics. Mol Psychiatry 2014[^3]: Neurexin structure-function relationships. Nat Rev Neurosci 2013[^4]: Alternative splicing of neurexin 3. Cell 2011[^5]: NRXN3 in synaptic transmission. J Neurosci 2016[^6]: Neurexin in behavior. Nat Neurosci 2015[^7]: Brain expression of NRXN3. Brain Struct Funct 2017[^8]: Neuroligin-neurexin specificity. Cell 2012[^9]: NRXN3 GWAS in addiction. Nat Genet 2013 ↩︎